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Key Points 38 
Questions: Are modifiable cardiovascular risk factors in young adults 39 
associated with cerebral blood vessel structure and function, and neuroimaging 40 
white matter hyperintensities?  41 
Results: In this cross-sectional study of 125 young adults without clinical 42 
evidence of cerebrovascular disease, a higher number of optimal 43 
cardiovascular health metrics was correlated with higher cerebral vessel 44 
density, higher cerebral blood flow, and lower white matter hyperintensity 45 
lesions. 46 
Meaning: These preliminary findings suggest a relationship between 47 
modifiable cardiovascular risk factors and MRI biomarkers of cerebrovascular 48 
structure and function and white matter hyperintensities in young adults. 49 
Further research is needed to verify these findings and determine clinical 50 
importance. 51 
  52 
 3 
Abstract 53 
Importance: Risk of stroke and brain atrophy in later life relate to levels of 54 
cardiovascular risk in early adulthood. However, it is unknown whether 55 
cerebrovascular changes are present in young adults. 56 
Objective: To examine relationships between modifiable cardiovascular risk 57 
factors and cerebrovascular structure, function and white matter integrity in 58 
young adults. 59 
Design, Setting, and Participants: A cross-sectional observational study of 60 
125 young adults (aged 18 to 40 years) without clinical evidence of 61 
cerebrovascular disease with data collection completed between August 2014 62 
and May 2016 at the University of Oxford, United Kingdom. Final data 63 
collection was completed on the 31st of May 2016. 64 
Exposures: The number of modifiable cardiovascular risk factors at 65 
recommended levels, based on the following criteria: BMI <25 kg/m2; highest 66 
tertile cardiovascular fitness and/or physical activity; alcohol <8 drinks/week; 67 
non-smoker for >6 months; blood pressure on awake ambulatory monitoring 68 
<130/80 mmHg; a non-hypertensive diastolic response to exercise (peak 69 
diastolic blood pressure <90 mmHg), total cholesterol <200mg/dL; and fasting 70 
glucose <100mg/dL. Participants were categorized from 0 to 8, with higher 71 
numbers indicating healthier risk categories.  72 
Main Outcomes and Measures: Cerebral vessel density (vessels/cm3), caliber 73 
(μm) and tortuosity, brain white matter hyperintensity lesion count (number), 74 
and in a subgroup (n=52) brain blood arrival time (seconds) and cerebral blood 75 
flow (ml/100g/min) assessed by brain magnetic resonance imaging. 76 
 4 
Results A total of 125 participants, mean age 25±5 years, 49% female, with a mean 77 
score of 6.0 (SD 1.4) modifiable cardiovascular risk factors at recommended levels, 78 
completed the cardiovascular risk assessment and brain MRI protocol. 79 
Cardiovascular risk factors were correlated with cerebrovascular morphology and 80 
white matter hyperintensity count in multivariable models. For each additional 81 
modifiable risk factor categorized as healthy, vessel density was greater by 0.3 82 
vessels/cm3 (95%CI 0.1 to 0.5, p=0.003), vessel caliber was greater by 8μm (95%CI 83 
3 to 13, p=0.01) and white matter hyperintensity lesions was lower by 1.6 lesions 84 
(95%CI 0.5 to 2.8, p=0.006). Among the 52 participants with available data, cerebral 85 
blood flow varied with vessel density and was 2.5ml/100g/min higher for each 86 
healthier category of a modifiable risk factor (95%CI 0.16 to 4.89, p=0.03). 87 
Conclusions and Relevance In this preliminary study, involving young adults 88 
without clinical evidence of cerebrovascular disease, modifiable cardiovascular 89 
risk factors were associated with MR indices of cerebral vessel structure and 90 
function, and white matter hyperintensities. Further research is needed to verify 91 
these findings and determine clinical importance. 92 
Key words: brain health, cardiovascular risk factors, young adults,  93 
 94 
  95 
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Introduction 96 
A life-course approach to understand risk of cardiovascular disease is well 97 
established1 and it is accepted that changes in cardiac and vascular structure that 98 
underlie this risk emerge very early in life2, 3. Whether modifiable cardiovascular risk 99 
factors, and novel early life exposures such as preterm birth, influence the early 100 
cerebrovasculature is less well studied.    101 
 102 
Cardiovascular risk closely relates to cerebrovascular injury and cognitive decline in 103 
older adults4. MRI markers of cerebral injury in mid-life, including white matter 104 
hyperintensity lesions, are associated with future stroke, dementia and all-cause 105 
mortality5. Progression of white matter hyperintensity lesions is faster in association 106 
with metabolic dysfunction and hypertension6. Experimental studies have 107 
demonstrated that cardiovascular risk factors result in remodelling of the brain 108 
vasculature, including vessel rarefaction, lower vessel caliber and cerebral blood 109 
flow7. Elevated blood pressure, dyslipidemia and low fitness in early adulthood are 110 
known to predict brain health in older adult life8-10. Whether cerebrovascular 111 
morphological changes are already evident in young adults, and correlate with white 112 
matter hyperintensity lesions and risk factors at this age, is unclear.   113 
 114 
Advances in brain MRI allow automated segmentation and analysis of vessel 115 
morphology, white matter hyperintensity lesions11, 12 and blood flow13; thus making it 116 
possible to estimate brain vascular and structural status for an individual11, 12.  117 
Therefore, the objective of the current study was to use multi-modality brain imaging 118 
to test the hypothesis that cardiovascular risk profiles are correlated with variation in 119 
vessel morphology and white matter hyperintensity lesions in young adults. 120 
 121 
 122 
 123 
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Methods 124 
Study design and participants 125 
This was a cross-sectional observational study completed between August 2014 and 126 
May 2016. The South Central Research Ethics Committee for the National Health 127 
Service Health Research Authority (NHS HRA) approved the study (14/SC/0275). All 128 
participants gave written informed consent. Measurements were completed at the 129 
Oxford Cardiovascular Clinical Research Facility and Oxford Centre of Clinical 130 
Magnetic Resonance Research, John Radcliffe Hospital, University of Oxford, United 131 
Kingdom. Image analysis was performed using pipelines developed at the Hotchkiss 132 
Brain Institute, University of Calgary and Wellcome Centre for Integrative 133 
Neuroimaging, University of Oxford12-16.  Final data collection was completed on the 134 
31st of May 2016. 135 
 136 
Participants aged 18 to 40 years were recruited through purposive active and 137 
passive recruitment17 including local advertising, invitation from local birth cohort 138 
studies and invitation from the Oxford University Hospital Hypertension Service. 139 
Strategies were designed to recruit adults with a heterogeneity in risk factors known 140 
to be present in young adult populations including traditional risk factors such as 141 
hypertension and more novel factors such as gestational age. Participants were 142 
excluded if they had previous cardiovascular or cerebrovascular events, renal 143 
dysfunction or metabolic disease including diagnosis of familial hyperlipidaemia. 144 
Participants with secondary causes of hypertension such as renal vascular disease, 145 
vascular anomalies or adrenal dysfunction were excluded following assessment in 146 
Oxford University Hospital Hypertension Service.  147 
 148 
 149 
 150 
 151 
 7 
Procedures 152 
Cardiovascular Risk Assessment 153 
Participants attended a research clinic in the morning after a 12-hour fast to complete 154 
a detailed cardiovascular risk assessment (Supplementary Data eMethods 1). 155 
Measurements included: body size, fasting blood samples for total cholesterol, high-156 
density lipoprotein, low-density lipoprotein, triglycerides, highly sensitive c-reactive 157 
protein, glucose, and insulin levels, clinic and 24-hour blood pressure, as well as 158 
peak oxygen uptake and exercise blood pressure (from cardiopulmonary exercise 159 
testing). In addition, participants completed a detailed lifestyle questionnaire and had 160 
seven complete days of objectively measured physical activity. Post-hoc, participants 161 
were assessed for a cardiovascular score based on 8 modifiable risk factors, with 1 162 
point awarded for each healthier category of a modifiable risk factor according to the 163 
following criteria: BMI <25 kg/m2; highest tertile cardiovascular fitness and/or physical 164 
activity; alcohol <8 drinks/week; non-smoker for >6 months; blood pressure on 165 
awake ambulatory monitoring <130/80 mmHg; a non-hypertensive diastolic response 166 
to exercise (peak diastolic blood pressure <90 mmHg), total cholesterol <200mg/dL; 167 
and fasting glucose <100mg/dL. The score was adapted from established 168 
cardiovascular health scores to include alcohol consumption and dynamic exercise 169 
blood pressure response, as known independent risk factors for brain health19-21. The 170 
thresholds for healthy criteria were set to be consistent with recommended public 171 
health guidelines and existing literature4, 9, 18-20.   172 
 173 
Brain Imaging and Analysis  174 
Individuals underwent a multimodality MRI scan (3.0T Trio Tim, Siemens, Munich, 175 
Germany). The MRI protocol included T1-weighted structural, T2-weighted Fluid-176 
Attenuated Inversion Recovery (FLAIR), Diffusion Tensor Imaging (DTI) and Time-of-177 
Flight (TOF) MR Arteriogram (MRA) (Supplementary Data eMethods 2). MR imaging 178 
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was completed fasted and prior to exercise testing. Complete acquisition and 179 
analysis methods are presented in the on-line supplement. 180 
 181 
T1-weighted images were processed using FMRIB Software Library (FSL) tools21. 182 
Brain vessel segmentation was completed on TOF MRA using previously described 183 
automated segmentation tools (supplement eFigure 1)12, 16. Binary segmentations 184 
were used to determine vessel density, caliber and tortuosity.  185 
 186 
White matter hyperintensity (WMH) lesions and associated volumes were segmented 187 
using the Brain Intensity AbNormality Classification Algorithm (BIANCA); a fully-188 
automated, supervised method for WMH detection11, 22.  BIANCA classifies image 189 
voxels based on their intensity and spatial features, where the intensity features were 190 
extracted from T2-weighted FLAIR, T1-weighted and DTI fractional anisotropy (FA) 191 
images, FA images were generated using DTI tools, FSL topup, FSL eddy and 192 
DTIFit21, 23. WMH masks were manually segmented from 10 images to use as the 193 
training set for BIANCA, these were independently verified by a neurologist (TS) and 194 
radiologist (DM) blinded to participant risk profile. Lesion count was selected as the 195 
most sensitive outcome of white matter change in young adults in whom a single 196 
lesion, independent of volume, could be considered abnormal24. Minimum lesion size 197 
used in analysis was 1 mm3.  198 
 199 
A subgroup of 52 participants also had multi-delay vessel-encoded 200 
pseudocontinuous Arterial Spin Labelling (ASL), identical to a previously published 201 
protocol13. Cerebral blood flow and blood arrival time were estimated from ASL 202 
images using a previously described analysis pipeline13, 15. Gray matter masks were 203 
used to calculate the average cerebral blood flow after linear registration of the ASL 204 
MRI to the T1-weighted MRI dataset. 205 
 206 
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 207 
Statistical Analysis 208 
Recruitment was continued to 125 participants for an estimated power of 90% 209 
at P=0.05 to identify a 0.70-SD difference in vessel density, vessel caliber and white 210 
matter lesion count between lowest and highest cardiovascular risk tertile groups. 211 
Arterial spin labelling (ASL) MRI imaging was added during the course of the study to 212 
provide a subgroup of 52 participants, recruited sequentially for an estimated 80% 213 
power to detect a 10% difference in cerebral blood flow25.  214 
 215 
Existing literature on risk predictors of brain health was used to define an a priori set 216 
of potential correlates of MRI brain health in young adults4, 9, 18-20.  These were 217 
grouped as: 1) non-modifiable, including age, sex, gestational age, and 2) modifiable, 218 
including systolic blood pressure, body mass index (BMI), peak exercise capacity 219 
(oxygen uptake ml/min/kg), peak exercise diastolic blood pressure, weekly vigorous 220 
activity level, alcohol consumption, smoking history, lipid profile, glucose and insulin 221 
resistance, and current hypertension medication.  222 
 223 
In a priori analysis, bivariable and multivariable analysis was completed to 224 
investigate correlation between the defined cardiovascular risk markers and brain 225 
imaging findings. In this multivariable analysis to reduce multiple testing and potential 226 
interaction between the variables, the model was restricted to a subset of variables 227 
(resting systolic blood pressure, BMI, vigorous physical activity level, alcohol 228 
consumption and smoking). This model was adjusted for non-modifiable factors 229 
including age, sex and gestational age.  230 
 231 
In post-hoc analysis, the individuals’ combined cardiovascular score from across 8 232 
risk factors, was used as a metric of overall modifiable cardiovascular health. The 233 
relationships between the individuals’ modifiable cardiovascular score and brain 234 
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imaging findings were studied using linear regression adjusted for age and sex.  235 
Comparison between brain imaging findings was made between groups of 236 
participants in the lowest and highest tertiles for the cardiovascular score.  237 
 238 
In addition, bivariable analysis was completed to investigate correlation between 239 
vessel morphology and white matter hyperintensity lesion count and in a subgroup 240 
(n=52), blood arrival time and cerebral blood flow. These relationships were further 241 
investigated with fixed entry linear regression models adjusted for modifiable and 242 
non-modifiable factors used in the models above.  243 
 244 
Statistical analysis was undertaken using Statistical Product and Service Solutions 245 
(SPSS) Version 22 (Armonk, New York, U.S). Normality of variables was assessed 246 
by visual assessment of curves. If normally distributed, results are presented as 247 
mean ± standard deviation for continuous variables, otherwise median and 248 
interquartile range. For categorical variables, number and percentage are presented. 249 
Comparison between groups for continuous variables was performed with a 2-sided, 250 
independent-sample Student’s t test. All multivariable analysis was completed using 251 
forced entry linear regression with residual analysis completed to assess model 252 
assumptions. All multivariable analyses were adjusted for age and sex.  All tests 253 
were 2-sided, P-values <0.05 were considered statistically significant with no 254 
adjustment for multiple comparison. Due to multiplicity of testing all results were 255 
considered exploratory. Results are presented as point estimates and 95% 256 
confidence intervals stated in units appropriate to the risk factor and brain imaging 257 
findings being reported. Graphpad Prism 7 software was used for statistical figures 258 
and mean with 95% confidence intervals presented.  259 
 260 
 261 
 262 
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 263 
Results 264 
A total of 125 participants completed the brain MRI protocol and cardiovascular risk 265 
assessment study measures. The mean age of participants was 24.7±5.0 years, 61 266 
participants were female (49%), the mean gestational age was 36.6±4.3 weeks, 267 
educational attainment was high with 86 completing University level education 268 
(68.8%), 29 participants had prior history of hypertension of which 21 were on anti-269 
hypertension medications (16.8%) (Table 1). The distributions of MRI brain outcomes 270 
between lowest and highest quintile of the respective measures are presented in the 271 
supplement (eTable 1).  The 52 participants with available cerebral blow flow data 272 
shared a comparable demographic profile as the overall study group (mean age 24.6 273 
±5.0 years, 42% female (n=22), gestational age 37.2±3.6 weeks, and 10 participants 274 
were on anti-hypertension medications (19.2%). 275 
 276 
Modifiable risk factors and association with brain vessel structure and white 277 
matter hyperintensity lesions 278 
Association between risk factors (SBP, BMI, smoking pack years, Ex DBP, 279 
cholesterol/HDL ratio, hypertension treatment) and brain vessel morphology are 280 
presented in Table 2. Vessel tortuosity only varied with gestational age in both 281 
bivariable and adjusted models (0.005 unit tortuosity change/gestational week, 282 
95%CI 0.001 to 0.009, p=0.007) (Table 2 and Supplementary Data, eTable 2). In the 283 
multivariable models, systolic blood pressure (-0.2 vessels/cm3 per 10mmHg, 95%CI 284 
-0.4 to -0.004, p=0.04), smoking (2 vessels/cm3 per 10 pack years, 95%CI 0.6 to 3.0, 285 
p=0.04) and body mass index (-0.1 vessels/cm3 per 1kg/m2, 95%CI -0.15 to -0.01, 286 
p=0.02) were significantly correlated with vessel density, while vessel caliber was 287 
correlated with systolic blood pressure (-6μm per 10mmHg, 95%CI -10.0 to -0.5, 288 
p=0.03) and smoking (40μm per 10 pack years, 95%CI 2.0 to 80.0, p=0.04). In 289 
bivariable models, number of white matter hyperintensity lesions correlated with 290 
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smoking (8 lesions per 10 pack years, 95%CI 1.5 to 14.4, p=0.02), exercise diastolic 291 
blood pressure (1 lesions per 10mmHg, 95%CI 0.1 to 2.4, p=0.04), and alcohol 292 
consumption (4 lesion per 10 weekly alcoholic drinks, 95%CI 0.3 to 8.0, p=0.03),  293 
(Supplementary Data, eTable 3). 294 
 295 
Healthier categories on the modifiable cardiovascular score correlated with vessel 296 
morphology (Table 4.) Each additional healthier category of risk factor was 297 
associated with a 0.3 vessels/cm3 higher vessel density (95%CI 0.1 to 0.5, p=0.003) 298 
and 8μm greater vessel caliber (95%CI 3.0 to 13.0, p=0.01). Similarly, white matter 299 
hyperintensity lesion count correlated with the cardiovascular score with 1.6 fewer 300 
white matter hyperintensity lesions per additional healthier category of risk factor 301 
(95%CI to -3.0 to -0.5, p=0.006). In addition, the cardiovascular score correlated with 302 
total volume of white matter hyperintensity adjusted for brain size with 51 mm3 lower 303 
white matter hyperintensity lesion volume per additional healthier category of risk 304 
factor (95%CI to -87 to -15 mm3 p=0.006). Differences in vessel morphology and 305 
white matter hyperintensity lesions between tertiles of the study group, divided based 306 
on the cardiovascular score, are presented in Figure 1. 307 
 308 
Vessel Morphology and brain MRI biomarkers of cerebral blood flow, arrival 309 
time and white matter lesion count 310 
To explore whether cerebral blood flow also varied with cardiovascular risk factors, a 311 
subgroup (n=52) analysis was performed in those with cerebral blood flow measures 312 
(mean cerebral blood flow 60 ml/100g/min (SD 11.5) and mean blood arrival time 313 
1.01 seconds (SD 0.08). Slower blood arrival time (0.1 seconds per 1kg/m2, 95%CI 314 
0.001 to 0.05, p=0.001) and lower cerebral blood flow (-1.1 ml/100g/min per 1kg/m2, 315 
95%CI -2.0 to -0.1, p=0.03) were correlated with higher BMI (Supplementary Data, 316 
eTable 3). Cerebral blood flow was also lower in correlation with anti-hypertensive 317 
medication 11 ml/100g/min (95%CI -18 to -3, p=0.007). Cerebral blood flow was 318 
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2.5ml/100g/min higher for each additional healthier category of the cardiovascular 319 
score (95%CI 0.16 to 4.89, p=0.03). There was no significant correlation between 320 
blood arrival time and the cardiovascular scores (Table 4). 321 
 322 
In multivariable analysis, controlling for modifiable risk factors (SBP, BMI, VPA, 323 
smoking, alcohol intake) blood arrival time and cerebral blood flow varied with 324 
cerebral vessel density, with each additional vessel per cm3 correlating with a 0.015 325 
seconds faster blood arrival time (95%CI -0.03 to -0.002, p=0.02) and 3 ml/100g/min 326 
increase in cerebral blood flow (95%CI 0.7 to 5.4, p=0.01). Vessel density was 327 
inversely correlated with white matter hyperintensity lesion count with 1.5 fewer 328 
lesions per unit increase in vessel density per cm3 (95%CI to -2.7 to -0.4, p=0.01). 329 
(Table 3).  330 
 331 
Discussion 332 
In this cross-sectional study, optimal status of modifiable cardiovascular risk factors 333 
in young adults were associated with differences in brain vessel structure and 334 
function as well as a lower number of white matter hyperintensity lesions. Higher 335 
vessel density correlated with both higher cerebral blood flow and lower white matter 336 
lesion counts.  337 
 338 
To date, studies tracking changes in brain vascular measures have largely focused 339 
on the transition from middle age to older adulthood. Cerebral blood flow is estimated 340 
to decline over the life course26 with risk of dementia in older adults being 2 to 3 fold 341 
higher in those whose cerebral blood flow is below 55 ml/100g/min27. Vascular 342 
dementia has also been associated with lower vascular density in brains of adults 343 
who have an early diagnoses of disease28. In the current study, young adults in the 344 
lowest tertile for the modifiable cardiovascular score had approximately 1 vessel/cm3 345 
lower vessel density and a mean value for cerebral blood flow of 55 ml/100g/min, 346 
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which is in the bottom 40% of the current study population. Therefore, the distribution 347 
of MRI findings observed in the current study raises the potential that some 348 
individuals may be starting to diverge on to different risk trajectories for brain 349 
vascular health in early adulthood. Furthermore, levels of cerebral blood flow 350 
associated with an increased risk of dementia are evident in some young adults. No 351 
participants had clinically significant white matter hyperintensity lesion volumes but 352 
lesion count was up to 4 lesions lower in the highest tertile of optimal status of 353 
modifiable risk factors. 354 
 355 
Adverse modifiable cardiovascular risk factors are major determinants of white 356 
matter hyperintensity progression29, with small lesions increasing in size or clustering 357 
into confluent lesions30. Accumulation of lesions from an early age might explain why, 358 
by mid-life, white matter hyperintensity lesion volume is an established predictor of 359 
future stroke and dementia risk5. The longitudinal relationships between vessel 360 
morphology, cerebral perfusion and white matter lesion burden are uncertain. 361 
However, the patterns observed in the current study may suggest that resilience of 362 
the white matter, and potential to withstand risk exposures, may be influenced by the 363 
vascular morphology of an individual.  364 
 365 
Modifiable risk factors such as blood pressure, BMI, smoking and lipid profile are 366 
known to drive systemic vascular disease in young adults in part through biological 367 
vascular disorders including endothelial dysfunction and oxidative stress31-33. The 368 
current study suggests the cerebrovasculature may be similarly affected. Novel early 369 
life factors, such as preterm birth, are linked with early vascular disease34 and the 370 
third trimester and early neonatal period are hypothesized to be times of significant 371 
vascular remodelling. In this study, gestational age was associated with vessel 372 
tortuosity, consistent with previous reports in infants35, but not other cerebrovascular 373 
measures. Further work is needed to understand whether this was because 374 
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participants were largely born late preterm or because cardiovascular risk profile 375 
overwhelms this early exposure.28.  376 
 377 
The observed association between brain vascular measures and modifiable risk 378 
factors raises the potential for targeted intervention to prevent progression to 379 
disease.  Reducing multiple risk factors can change risk trajectories and reduce 380 
vascular disease burden36, with sustained lifestyle intervention and active blood 381 
pressure lowering associated with lower burden of white matter hyperintensity 382 
lesions and improved cerebral perfusion37, 38.  These interventions typically achieve 383 
25% improvements in cardiovascular fitness and 10 mmHg reductions in blood 384 
pressure37, 38, comparable to differences between high and low tertile groups for the 385 
cardiovascular scores in this study.   386 
 387 
However, lifestyle-based primary cardiovascular prevention in young adults requires 388 
complex intervention design. Recent systematic review of interventions in young 389 
hypertensives demonstrated that the optimal way to intervene is poorly understood 390 
with lack of sustained effect39. The alternative to lifestyle interventions would be 391 
pharmacological treatment. However, in this study group higher blood pressure was 392 
associated with reduced vessel density and anti-hypertensive use was associated 393 
with lower cerebral blood flow. Therefore, further work to identify optimal 394 
interventions in young adults to maintain autoregulation of cerebral blood flow, while 395 
reducing risk, may be required.  396 
 397 
Limitations 398 
This study has several limitations. First, a small sample recruited at a single site 399 
increases risk of bias and type 1 error while the study may be underpowered to 400 
identify subtle correlations with some risk factors. Second, purposive mixed passive 401 
and active recruitment strategies mean the sample is not population-based and could 402 
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be considered similar to a convenience sample. Therefore, it is not possible to 403 
generalise expected prevalence of cerebrovascular changes to the wider population. 404 
Third, the study is cross-sectional and causality or even temporality of the observed 405 
relationships cannot be inferred. Fourth, the cardiovascular risk assessment would 406 
be strengthened by detailed dietary questionnaires which were not included in this 407 
study. Fifth, cerebral blood flow was only available in a subgroup so ability to 408 
understand interactive effects of modifiable risk factors, vascular remodelling and 409 
perfusion on white matter integrity is limited. Sixth, longitudinal follow up will be 410 
required to determine the clinical significance of the observed findings. As such, this 411 
study should be considered preliminary and exploratory but does support a need for 412 
future work. The complexity of the imaging protocol and associated financial costs 413 
may limit its widespread use but large multi-centre studies with more focused 414 
protocols, and extended follow up, may have the potential to track vascular 415 
remodelling and assessment of impact on white matter and later disease.  416 
 417 
Conclusion 418 
In this preliminary study involving young adults without clinical evidence of 419 
cerebrovascular disease, modifiable cardiovascular risk factors were associated with 420 
MRI indices of cerebral vessel structure and function, and white matter 421 
hyperintensities. Further research is needed to verify these findings and determine 422 
clinical importance. 423 
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Table 1. Age, demographics and cardiovascular risk profile of study group. 588 
 Study Group (n=125) 
Demographics  
Age, mean (SD), years 24.7 (5.0) 
Female, n, (%) 61 (49%) 
Gestational Age, mean (SD), weeks 36.6 (4.3) 
Smoking, n, (%) 19 (15.2) 
Smokers’ median pack years (Q1-Q3) 2.7 (6.7)  
Alcohol, n, (%) 97 (77.6) 
Alcohol consumers’ median drinks per week (Q1-Q3) 4.0 (4.0) 
Hypertension Diagnosis, n, (%) 29 (23.0) 
Taking Hypertension Medication, n (%) 21 (16.8) 
FHx Stroke or CHD, n, (%) 10 (8) 
Education Level  
Completed University, n, (%) 86 (68.8) 
Anthropometrics  
Height, mean (SD), m 1.73 (0.1) 
Weight, mean (SD), kg 70.9 (13.8) 
BMI, mean (SD), kg/m2 23.6 (3.7) 
Blood pressure, mean (SD), mmHg   
Resting Systolic 122.0 (11.6) 
Resting Diastolic 71.3 (9.55) 
Ambulatory Awake Systolic 129.6 (11.8) 
Ambulatory Awake Diastolic 76.9 (8.0) 
Peak Exercise Systolic 174.8 (25.4) 
Peak Exercise Diastolic 87.1 (12.4) 
Fitness  
Peak VO2, mean (SD), ml/kg/min 37.9 (9.6) 
Peak Respiratory Exchange Ratio, mean (SD) 1.2 (0.06) 
VPA, median (Q1-Q3), hours per week 0.74 (1.25) 
MVPA, median (Q1-Q3), hours per week 14.73 (6.09) 
Biochemistry  
Total Cholesterol, mean (SD), mg/dL 170.15 (29.0) 
LDL, mean (SD), mg/dL 97.45 (25.9) 
HDL, mean (SD), mg/dL 55.68 (11.2) 
TChol:HDL ratio, mean (SD) 3.18 (0.85) 
Triglyceride, median (IQR), mg/dL  74.4 (54.0) 
Blood Glucose, mean (SD), mg/dL 88.2 (7) 
HOMA-IR, mean (SD) 0.77 (0.46) 
HsCRP, median (Q1-Q3), mg/L 0.57 (1.16) 
Brain MRI Vessel, Perfusion and White Matter Parameters  
Brain vessel density, mean (SD), vessels/cm3 8.3 (1.41) 
Brain vessel calibre, mean (SD), μm 531 (36) 
Brain vessel tortuosity, mean (SD) 1.49 (0.088) 
Brain white matter hyperintensity lesion count, mean (SD) 20.9 (7.9) 
Brain Blood Arrival Time (SD), seconds 1.01 (0.08) 
Cerebral Blood Flow (SD), ml/100g/min 60 (11.5) 
Abbreviations: FHx, Family History, BMI, body mass index; SBP, systolic blood 589 
pressure; DBP, diastolic blood pressure; Peak VO2, Peak Oxygen Uptake; VPA, 590 
Vigorous Physical Activity; MVPA, Moderate to Vigorous Physical Activity; LDL, low 591 
density lipoprotein; HDL, high density lipoprotein; T Chol: total cholesterol; HsCRP, 592 
highly sensitive C reactive protein; HOMA-IR, homeostatic model assessment of 593 
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insulin resistance. Brain blood arrival time and cerebral blood flow data was available 594 
in 52 participants. 595 
  596 
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Table 2.  Association between non-modifiable and modifiable risk factors and 597 
brain vessel morphology (vessel density, caliber and tortuosity). 598 
 599 
Also modelled was the association between these risk factors and tortuosity, and 600 
only gestational age was related, full analysis presented in supplement (eTable 1).  601 
Model adjusted for non-modifiable factors of age, sex, gestational age and modifiable 602 
risk factors of systolic blood pressure, body mass index, vigorous physical activity, 603 
weekly alcohol consumption and smoking status. Abbreviations and units: SBP, 604 
systolic blood pressure (mmHg); BMI, body mass index (kg/m2); VPA, Vigorous 605 
Physical Activity (hours per week); Alcohol (drinks per week); Smoking (pack years); 606 
Peak VO2, Peak Oxygen Uptake (ml/kg/min); Ex DBP, Peak exercise diastolic blood 607 
pressure (mmHg), Cholesterol/HDL ratio, ratio total cholesterol/high density 608 
lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance, 609 
 Bivariable 
Point Estimate  
(95 %CI) 
P value 
 
Adjusted 
Point Estimate 
(95 %CI) 
 
P value 
Brain Vessel Density 
(vessels/cm3) 
  Model Statistics 
R2=0.20 p =.009 
 
 
Gestational Age, weeks -0.001 (-0.06 to 0.06) .98 -0.02 (-0.08 to 0.03) .42 
Resting SBP, mmHg -0.03  (-0.05 to -0.004) .02 -0.02 (-0.04 to -0.0004) .046 
BMI, kg/m2 -0.10 (-0.16 to -0.02) .01 -0.08 (-0.15 to -0.01) .02 
VPA, hours per week 0.10 (-0.17 to 0.39) .42 -0.04 (-0.28 to 0.20) .75 
Alcoholic drinks per week -0.10 (-0.025 to -0.008) .31 -0.01 (-0.04 to 0.02) .41 
Smoking pack years 0.20 (0.06 to 0.30) .004 0.17(0.06 to 0.28) .004 
Peak VO2, ml/kg/min 0.01 (-0.02 to 0.04) .5 . . 
Peak Ex DBP, mmHg -0.02 (-0.04 to -0.003) .047 . . 
Cholesterol/HDL Ratio -0.40 (-0.69 to -0.06) .02 . . 
HOMA IR -0.56 (-1.17 to 0.04) .07 . . 
Hypertension Rx 0.75 (-0.01 to 1.5) .05  . . 
Brain Vessel Caliber 
(μm) 
  Model Statistics 
R2=0.24 p=.001 
 
 
Gestational Age, weeks -0.1 (-2.0 to 1.0) .88 -1.0 (-3.0 to 0.5) .16 
Resting SBP, mmHg -0.4 (-1.0 to 2.0) .15 -0.6 (-1.0 to -0.05) .03 
BMI, kg/m2 -1.0 (-3.0 to 1.0) .33 -1.0 (-3.0 to 1.0) .42 
VPA, hours per week 1.0 (-6.0 to 8.0) .73 -2.0 (-9.0 to 4.0) .49 
Alcoholic drinks per week -0.1 (-1.0 to 1.0) .70 -1.0 (-2.0 to 0.1) .09 
Smoking pack years 3.0 (-0.2 to 6.0) .06 4.0 (0.2 to 8.0) .04 
Peak VO2, ml/kg/min 0.4 (-0.2 to 1.0) .19 . . 
Peak Ex DBP, mmHg -1.0 (-1.4 to -0.4) <.001 . . 
Cholesterol/HDL Ratio -3.0 (-10.0 to 5.0) .52 . . 
HOMA IR -14.0 (-30 to 1.0) .08 . . 
Hypertension Rx 10 (-9.0 to 31.0) .27 . . 
Brain Vessel Tortuosity   Model Statistics 
R2=0.1 p=.26 
 
 
Gestational Age, weeks 0.005 (0.001 to 0.009) .007 0.006 (0.001 to 0.01) .01 
 24 
Hypertension Rx participant taking prescription medications for hypertension 610 
(yes/no).  Exposure variables were available for all participants. The point estimate 611 
refers to the magnitude of change in the vessel morphology variable per unit change 612 
in the non-modifiable and modifiable variables. 613 
  614 
 25 
Table 3. Association of vessel morphology (density, caliber, tortuosity) 615 
with measures of brain blood arrival time, cerebral blood flow and white 616 
matter hyper-intensity lesions 617 
 618 
 619 
Model adjusted for non-modifiable factors of age, sex, gestational age and 620 
modifiable risk factors of systolic blood pressure, body mass index, vigorous 621 
physical activity, weekly alcohol consumption and smoking status. Also 622 
modelled were the association with vessel caliber and tortuosity, only vessel 623 
density was related. The point estimate refers to the magnitude of change in blood 624 
arrival time, cerebral blood flow or number of white matter hyperintensity lesions per 625 
unit change in respective vessel morphological variable.  626 
 627 
 628 
 Bivariable 
Point Estimate  
(95 %CI) 
P 
Value 
Adjusted  
Point Estimate 
(95 %CI) 
 
P 
Value 
Blood Arrival Time 
(seconds) (n=52) 
 
    
Brain Vessel Density, 
vessels/cm3 
-0.03 (-0.04 to -0.01) .002 -0.015 (-0.03 to -0.002) 
 
.02 
Brain Vessel Caliber, 
μm 
0.08 (-0.61 to 0.78) .81 0.22 (-0.28 to 0.71) .38 
Brain Vessel Tortuosity 0.13 (-0.15 to 0.4) 0.36 -0.014 (-0.23 to 0.21) .90 
Cerebral Blood Flow   
(ml/100g/min) (n=52) 
 
    
Brain Vessel Density, 
vessels/cm3 
4.0 (1.8 to 6.2) .001 3.1 (0.7 to 5.4) 
 
.01 
Brain Vessel Caliber, 
μm 
48.6 (-50.3 to 147.6) .34 -8.0 (-126.1 to 110.1) .89 
Brain Vessel Tortuosity 3.8 (-36.4 to 44.1)  .85 12.9 (-35.4 to 61.1)  .60 
White Matter 
Hyperintensity Lesion 
Count (lesions) 
(n=125) 
 
    
Brain Vessel Density, 
vessels/cm3 
-1.1 (-2.2 to 0.06) .06 -1.5 (-2.7 to -0.4) .01 
Brain Vessel Caliber, 
μm 
13.5 (-31.3 to 58.4) .55 12.1 (-34.5 to 57.8) .61 
Brain Vessel Tortuosity -17.5(-35.3 to 0.24) .05 -11.0 (-29.0 to 7.0) .23 
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 629 
 630 
 631 
 632 
Table 4. Modifiable cardiovascular score and association with brain vessel 633 
morphology, cerebral blood flow and white matter hyperintensity lesion count  634 
 635 
Participants were assessed for a cardiovascular score, for each healthier category of 636 
a modifiable risk factor according to the following criteria: BMI <25 kg/m2; highest tertile 637 
cardiovascular fitness and/or physical activity; alcohol <8 drinks/week; non-smoker for 638 
>6 months; blood pressure on awake ambulatory monitoring <130/80 mmHg; a non-639 
hypertensive diastolic response to exercise (peak diastolic blood pressure <90 640 
mmHg), total cholesterol <200mg/dL; and fasting glucose <100mg/dL. Adjusted for 641 
age and sex. The point estimate refers to the magnitude of change in the dependent 642 
variable per unit change in the modifiable cardiovascular score.643 
Modifiable 
Cardiovascular  
Score  
Brain 
Vessel 
Density, 
vessels/cm3 
point 
estimate 
(95%CI) 
 
Brain 
Vessel  
Caliber, μm 
point 
estimate 
(95%CI) 
 
Brain Vessel 
Tortuosity 
point estimate 
(95%CI) 
 
Brain Blood 
Arrival Time, 
seconds 
(n=52) 
point estimate 
(95%CI) 
 
Cerebral 
Blood Flow, 
ml/min/100g 
(n=52) 
point estimate 
(95%CI) 
 
Brain white 
matter 
hyperintensity 
lesion count, 
number  
point estimate 
(95%CI) 
1 (n=2) 9.2 
(6.4 to 11.9) 
505 
(437 to 573) 
1.52 
(1.44 to 1.50) 
. . 36.2  
(24.3 to 48.0) 
2 (n=0) . . . . . . 
3 (n=4) 6.9  
(5.0 to 8.8) 
518 
(470 to 565) 
1.49  
(1.46 to 1.52) 
1.26  
(1.16 to 1.36) 
66.6  
(50.4 to 82.0) 
24.0  
(16 to 32) 
4 (n=14) 7.4  
(6.6 to 8.2) 
512 
(493 to 532) 
1.47  
(1.45 to 1.53) 
1.22 
(1.16 to 1.27) 
54.2  
(45.5 to 63.0) 
25.0  
(21.0 to 29.2) 
5 (n=27) 8.0  
(7.4 to 8.5) 
524  
(510 to 540) 
1.51  
(1.47 to 1.55) 
1.21  
(1.16 to 1.26) 
54.6  
(47.0 to 62.0) 
22  
(19.0 to 25.3) 
6 (n=36) 8.5 
(8.0 to 9.0) 
533  
(521 to 545) 
1.49  
(1.46 to 1.52) 
1.19  
(1.15 to 1.23) 
60.2  
(54.0 to 67.0) 
21.0  
(19.0 to 24.0) 
7 (n=33) 8.5  
(8.0 to 9.0)  
542  
(530 to 555) 
1.48  
(1.45 to 1.52) 
1.18  
(1.14 to 1.22) 
64.0  
(57.8 to 70.0) 
19.0  
(16.2 to 21.8) 
8 (n=9) 9.1  
(8.2 to 10.0) 
540  
(518 to 563) 
1.54  
(1.46 to 1.62) 
1.18  
(1.11 to 1.24) 
68.0  
(57.6 to 78.1) 
20.0  
(15.4 to 26.6) 
Change in point 
estimate per 
additional score 
(n=125) 
0.31  
(0.112 to 
0.514) 
8.0  
(3.0 to 13.0) 
0.005  
(-0.008 to 0.18) 
-0.014  
(-0.03 to 0.001) 
2.5  
(0.16 to 4.89) 
-1.6  
(-3.0 to -0.5)   
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Figure 1. Comparison of white matter lesion count and vessel morphology between groups of participants based on their modifiable 
cardiovascular score. 
 
 
 
The cardiovascular score provided a cumulative score for each of the following factors: high cardiovascular fitness (top tertile of peak oxygen uptake (>=110% 
predicted peak oxygen uptake) or participating in >=75 minutes vigorous physical activity per week); not smoking in last 6 months; alcohol <8 drinks/week; 
ambulatory awake blood pressure <130/80mmHg; body mass index <25kg/m2; fasting total cholesterol <200 mg/d; fasting blood glucose <100 mg/dL; and 
diastolic blood pressure at peak exercise <= 90mmHg. Figure 1 presents a post-hoc comparisons between groups of participants who score 0 to 5 positive 
factors (n=47), 6 factors (n=36) and 7 to 8 positive factors (n=42). The groupings were defined to approximate tertiles of the combined cardiovascular score. 
Panel A presents the white matter lesions counts for individual participants and associated group mean and 95% CI, Panels B and C present the mean group 
values and 95% CI. Participants with 7 to 8 healthier categories of risk factor have a mean vessel density 11% higher than participants with 0 to 5 healthier 
categories of risk factor (Panel B, 8.6 vessels/cm3 (SD 1.39) vs 7.8 vessels/cm3 (SD 1.21) p=0.007), a mean vessel caliber 3% higher (Panel C, 538μm (SD 
21) vs 522μm (SD 45) p=0.02) and on average 20% lower white matter hyperintensity lesion counts (Panel A, 19.6 lesions (SD 7.8) vs 23.5 lesions (SD 8.6) 
p=0.03). Panels present group means and 95%CI and reported group differences are adjusted for age and sex. 
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eMethod1. Detailed description of cardiovascular risk assessment.  
Participants attended a research clinic in the morning after a 12-hour fast. 
Body size was measured at a combined digital height and weight station 
(Seca 798, Seca, Hamburg, Germany). Participants completed a detailed 
questionnaire on medical history, socioeconomic status, and self-reported 
behaviours such as nutritional intake, smoking and alcohol consumption. 
Fasting blood samples were drawn, centrifuged, separated within 30 minutes, 
and stored at −80°C for later analysis. Total cholesterol, high-density 
lipoprotein, triglycerides, glucose, and insulin levels were measured at the 
John Radcliffe Biochemistry Laboratory. Low-density lipoprotein was 
calculated by Friedewald formula and insulin resistance by homeostatic model 
assessment1, 2.  Blood pressure was reported as mean of three measures 
recorded supine after five-minute rest using a size appropriate cuff and an 
automatic blood pressure monitor (A & D Instruments Ltd., Japan). 
Cardiopulmonary exercise test was completed on a stationary cycle 
ergometer (Ergoline GmbH, Germany) using an incremental exercise 
protocol. Participants began with a one-minute rest period followed by two-
minute warm-up at 20 Watts. They were instructed to maintain a rate of 60 
revolutions per minute (RPM) throughout the test. To limit total exercise 
duration to approximately 8-12 minutes the initial workload started at 35 to 75 
Watts dependent on self-reported fitness. Workload then incremented 15 
Watts per minute. Heart rate was recorded using continuous ECG monitoring, 
and manual blood pressure was recorded every third minute and at peak 
exercise. Participants were encouraged to exercise until exhaustion prevented 
3  
them from maintaining at least 50 RPM or established safety termination 
criteria were met3, 4. Participants reported perceived exertion scores 
throughout and respiratory exchange ratio was used as secondary criteria to 
validate peak exercise was reached. Predicted peak oxygen uptake was used 
to calculate the percentage achieved of predicted peak vo25.  Breath by 
breath data was averaged over 15 seconds and peak exercise parameters 
reported as the highest averaged values over sequential 30-second 
periods6.  At the end of the study, participants were asked to wear a 24 hour 
ambulatory blood pressure monitor to record awake average blood pressure 
readings with recordings every 30 minutes. A wrist worn triaxial accelerometer 
was worn for nine days to provide seven complete days of objectively 
measured physical activity7.  
 
eMethods 2. Detailed description of brain magnetic resonance image 
acquisition and analysis.  
Individuals underwent multimodality brain MRI scanning on a Siemens 3.0T 
scanner (Siemens, Munich, Germany). MRI imaging was completed prior to 
the exercise and cardiovascular risk assessment described above. All study 
measures were completed within 48 hours. MRI protocol included T1-
weighted structural imaging (TR/TE = 2040/4.7 ms, flip angle 8°, FOV 200 
mm, voxel size 1.0 mm isotropic), T2-weighted FLAIR (TR/TE = 9000/90 ms, 
flip angle 150°, FOV 220 mm voxel size 1.1 x 0.9 x 3.0 mm), Diffusion Tensor 
Imaging (DTI) (TR/TE = 8900/95 ms, 2.0 mm isotropic resolution, multiband 
echo-planar imaging (EPI), 64 slices, 64 diffusion weighted directions, FOV 
192 mm, b-value 1500s/mm2, five non-diffusion weighted images, b-value 
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0s/mm2, with one b0 volume acquired in the reverse phase encoded 
direction), Time-of-Flight (TOF) MRA (TR/TE  = 23/8 ms, flip angle 10°, FOV 
300 mm voxel size 1.6 x 1.2 x 5.0 mm) and in a subgroup of 52 patients multi-
delay vessel-encoded pseudocontinuous Arterial Spin Labelling (ASL), 
identical to a previously published protocol8. Brain vessel segmentation was 
completed on TOF MRA imaging using previously described automated 
segmentation tools (Figure 1)9, 10. The binary segmentations were used to 
determine overall vessel density, average caliber and tortuosity. All vessel 
segmentation results were visually checked to ensure proper quality. Vessel 
tortuosity was defined by the deviation from the shortest path between two 
points. This analysis was implemented by identifying the vessel endpoints and 
bifurcations, calculating the shortest path and the length of the actual 
centerline between each two connected points. The final tortuosity was then 
calculated by the ratio and it was averaged over all vessel segments. Cerebral 
perfusion and arrival time were estimated from ASL images using a previously 
described analysis pipeline8, 11. White matter hyperintensity (WMH) lesions 
were automatically segmented on FLAIR images with BIANCA (Brain Intensity 
AbNormality Classification Algorithm) a fully-automated, supervised method 
for WMH detection12, 13. BIANCA classifies the image’s voxels based on their 
intensity and spatial features, where the intensity features were extracted from 
T2-weighted FLAIR, T1-weighted and DTI fractional anisotropy (FA) images, 
FA images generated using established DTI tools, FSL topup, FSL eddy and 
DTIFit14-17. WMH masks were manually segmented from 10 images to use as 
the training set for BIANCA, these were independently verified by a 
neurologist (TS) and radiologist (DM). BIANCA probability output maps were 
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all visually checked for quality. Lesion count was selected as the most 
sensitive outcome of white matter change in this young adult population in 
which the presence of a single lesion, independent of volume, could be 
considered abnormal. The minimum lesion size used in analysis was 1 mm3. 
T1-weighted structural images were processed using FSL16 to generate gray 
matter masks which were used to calculate the average cerebral blood flow 
after linear registration of the ASL MRI to the T1-weighted MRI dataset. 
 
 
 
 
eTable 1 Quintile distribution of Brain MRI measures and mean 
difference between top and bottom quintile. 
 
 
Brain Measure Quintile 1 
Mean (SD) 
Quintile 5 
Mean (SD) 
Mean Difference 
between 1st and 5th 
quintile of respective 
measure  
Mean ((95%CI) 
Relative percentage 
difference between 
1st and 5th quintile of 
respective measure 
Brain Vessel Density, 
vessels/cm3 (n=125) 
6.6 (0.62) 10.5 (0.95) 3.8 (3.3 to 4.4) 37% lower vessel 
density 
Brain Vessel Calilber, μm 
(n=125) 
504 (56) 587 (47) 82  (61 to 103) 14% lower vessel 
caliber 
Brain Vessel Tortuosity 
(n=125) 
1.40 (0.02) 1.64 (0.05) 0.241 (0.22 to 0.27) 15% lower tortuosity 
Brain white matter 
hyperintensity lesion count, 
number (n=125) 
34.5 (4.5) 11 (2) 23 (21 to 25) 3 fold higher in first 
quintile 
Brain Blood Arrival Time, 
seconds (n=52) 
 
1.31 (0.03) 1.08 (0.02) 0.22 (0.2 to 0.25) 20% slower arrival 
time in the first 
quintile 
Cerebral Blood Flow, 
ml/min/100g (n=52) 
46 (4.7) 78 (8) 32 (25 to 38) 41% lower cerebral 
blood flow in the first 
quintile 
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eTable 2 Association between non-modifiable and modifiable risk 
factors and brain vessel tortuosity. 
 
 
 
 
Model adjusted for non-modifiable factors of age, sex, gestational age and 
modifiable risk factors of systolic blood pressure, body mass index, vigorous 
physical activity, weekly alcohol consumption and smoking status. 
Abbreviations and units: SBP, systolic blood pressure (mmHg); BMI, body 
mass index (kg/m2); VPA, Vigorous Physical Activity (hours per week); Alcohol; 
Smoking (pack years); Peak VO2, Peak Oxygen Uptake (ml/kg/min); Ex DBP, 
Peak exercise diastolic blood pressure (mmHg), Cholesterol/HDL ratio, ratio 
total cholesterol/high density lipoprotein; HOMA-IR, homeostatic model 
assessment of insulin resistance, Hypertension Rx participant taking 
prescription medications for hypertension (yes/no). The point estimate refers to 
the magnitude of change in vessel tortuosity per unit change in the non-
modifiable and modifiable variables. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Point Estimate  
(95 %CI) 
P value Adjusted effects 
Point Estimate  
(95 %CI) 
P value 
Brain Vessel Tortuosity   Model Statistic   
R2=0.10 p=.26 
 
 
Gestational Age, weeks 0.005 (0.001 to 0.009) .007 0.006 (0.001 to 0.01) .01 
Resting SBP, mmHg -0.00003(-0.001 to 0.001) .97 0.0003 (-0.001 to 0.002) .74 
BMI, kg/m2 -0.001 (-0.004 to 0.005) .75 -0.0003 (-0.006 to 0.005) .90 
VPA, hours per week -0.002 (-0.015 to 0.02) .81 -0.002 (-0.021 to 0.016) .81 
Alcohol, drinks per week -0.001 (-0.002 to 0.003) .61 -0.001 (-0.003 to 0.002) .60 
Smoking, pack years -0.005 (-0.13 to 0.002) .15 -0.008 (-0.017 to 0.001) .09 
Peak VO2,, ml/kg/min  0.001 (-0.001 to 0.003) .16 . . 
Peak Ex DBP, mmHg -0.001 (-0.001 to 0.002) .36 . . 
Cholesterol/HDL Ratio 0.009 (-0.01 to 0.03) .37 . . 
HOMA IR 0.008 (-0.031 to 0.046) .68 . . 
Hypertension Rx -0.004 (-0.05 to 0.04) .87 . . 
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eTable 3 Association between modifiable risk factors, brain blood arrival 
time, cerebral blood flow and white matter hyperintensity lesion count. 
 
 
Abbreviations and units: SBP, systolic blood pressure (mmHg); BMI, body 
mass index (kg/m2); VPA, Vigorous Physical Activity (hours per week); Alcohol; 
Smoking (pack years); Peak VO2, Peak Oxygen Uptake (ml/kg/min); Ex DBP, 
Peak exercise diastolic blood pressure (mmHg), Cholesterol/HDL ratio, ratio 
total cholesterol/high density lipoprotein; HOMA-IR, homeostatic model 
Blood Arrival Time Point Estimate  
(95 %CI) 
P value 
Gestational Age, weeks 0.003 (-0.003 to 0.01) .27 
SBP, mmHg 0.001(-0.01 to 0.03) .14 
BMI, kg/m2 0.011 (0.001 to 0.05) .001 
VPA, hours per week 0.001(-0.023 to 0.026) .91 
Alcohol, drinks per week -0.00015 (-0.0015 to 0.0015) .88 
Smoking, pack years -0.001 (-0.011 to 0.009) .84 
Peak Vo2, ml/kg/min 0.002  (-0.001 to 0.004) .17 
Peak Ex DBP, mmHg -0.001 (-0.003 to 0.001) .48 
Cholesterol/HDL Ratio 0.02 (-0.005 to 0.045) .11 
HOMA IR 0.012 (-0.062 to 0.085) .75 
Hypertension Rx (yes/no) -0.02 (-0.08 to 0.04) .46 
Cerebral Blood Flow   
Gestational Age, weeks -0.441 (-1.3 to 0.45) .32 
SBP, mmHg -0.213 (-0.484 to 0.082) .16 
BMI, kg/m2 -1.06 (-2.01 to -0.1) .03 
VPA, hours per week 1.52 (-2.02 to 5.06) .86 
Alcohol, drinks per week 0.01 (-0.23 to 0.25) .93 
Smoking, pack years -0.395 (-1.8 to 1.01) .58 
Peak Vo2, ml/kg/min 0.065 (0.27 to 0.4) .70 
Peak Ex DBP, mmHg -0.178 (-0.48 to 0.13) .24 
Cholesterol/HDL Ratio -2.15 (-5.8 to 1.5) .24 
HOMA IR -8.0 (-18.3 to 2.35) .13 
Hypertension Rx (yes/no) -10.8 (-3.2 to 18.4) .007 
 
White matter hyperintensity   
lesion count 
  
Gestational Age, weeks -0.22 (-0.56 to 0.12) .21 
SBP, mmHg 0.07 (-0.05 to 0.20) .26 
BMI, kg/m2 -0.04 (-0.44 to 0.36) .84 
VPA, hours per week -0.07 (-1.6 to 1.5) .93 
Alcohol, drinks per week 0.42 (0.03 to 0.80) .034 
Smoking, pack years 0.79 (0.15 to 1.44) .017 
Peak Vo2, ml/kg/min -0.05 (-0.20 to 0.11) .54 
Peak Ex DBP, mmHg 0.125 (0.007 to 0.244) .038 
Cholesterol/HDL Ratio -0.21 (-1.98 to 1.56) .82 
HOMA IR -0.12 (-3.49 to 3.25) .94 
Hypertension Rx (yes/no) 2.26 (-1.6 to 6.2) .25 
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assessment of insulin resistance, Hypertension Rx participant taking 
prescription medications for hypertension (yes/no). Exposure variables were 
available for all participants. The point estimate refers to the magnitude of 
change in blood arrival time, cerebral blood flow or number of white matter 
hyperintensity lesions per unit change in the non-modifiable and modifiable 
variables. 
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A1 
A2 
eFigure 1. Rows A1 and A2 provide a case comparison of the MRI imaging modalities and analysis tools used to assess brain vessel 
morphology, white matter lesion count, and cerebral blood flow.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3D Reconstruction of Brain Vessels 
segmented from Time of Flight MRI 
arteriogram 
Probability map of white matter 
hyperintensity lesions overlaid 
on Axial FLAIR image 
Axial arterial spin labelled images 
demonstrating cerebral blood flow 
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Time of Flight (TOF) magnetic resonance arteriogram was used to acquire images of the brain vessels, this was analyzed using automated tools 
generating binary segmentations to determine overall vessel density, caliber and tortuosity. 3D reconstructions of Time of Flight images which 
demonstrate segmented brain vessels are provided in column one of rows A1 and A2. Three image modalities T2 weighted Fluid Attenuated 
Inversion Recovery (FLAIR), Diffusion Tensor Imaging (DTI) and T1 weighted structural images were used to optimise white matter segmentation 
and white matter hyperintensity lesion quantification using analysis tools from the Brain Intensity AbNormality Classification Algorithm (BIANCA). 
BIANCA is a fully automated, supervised method for white matter hyperintensity detection, based on the k-nearest neighbour (k-NN) algorithm. 
The BIANCA output is a probability map of the likelihood that the voxel being classified is a lesion. The probability map is displayed in column 2 
of rows A1 and A2, on a spectrum of orange to yellow, and overlaid on an axial FLAIR image for comparison. Voxels likely to be white matter 
hyperintensity lesions are demonstrated as bright yellow.  A threshold of 0.9 was applied to define the voxel as lesion or not which was then fed 
into cluster analysis to identify individual lesions and quantify white matter hyperintensity volumes. White matter hyperintensity lesions are 
demonstrated as bright yellow. In a subgroup of the study population (n=52) pseudocontinuous vessel selective arterial spin labelling (ASL) was 
acquired to allow the assessment of blood flow to the brain. This provides two outputs, a measure of blood arrival time (seconds), and a measure 
of cerebral blood flow (ml/100g/min) demonstrated in column 3, of rows A1 and A2. The different colours on cerebral blood flow images 
correspond with the contributing vessels (RICA, right internal carotid artery; LICA, left internal carotid artery; RVA, right vertebral artery; LVA, left 
vertebral artery.) 
Rows A1 and A2 provide a comparison between two young adults with visible differences in brain MRI findings that may be associated with 
differences in the number of healthier categories on the cardiovascular score. Vessel morphology quantified using Time of Flight imaging is 
presented in column 1,  and white matter intensity lesion count quantified using BIANCA analysis tools presented in column 2 and cerebral blood 
flow measured using ASL presented in columns 3.  Participant A1 is a 21 year old male with BMI 26 kg/m3, resting blood pressure 144/81 mmHg, 
awake ambulatory blood pressure 135/74 mmHg, 40 minutes of vigorous activity and 14 hours of moderate to vigorous activity per week 
measured on trixial accelerometer, non-smoker with alcohol intake greater than 8 drinks per week, blood pressure at peak exercise measured 
200/70 mmHg, total cholesterol 178 mg/dl and fasting blood glucose 77 mg/dl. Participant A1 vessel density measures 6.4 vessels/cm3, he has 
30 white matter hyperintensity lesions measuring 1mm or more and cerebral blood flow was 62ml/100g/min (lower intensity on colour scale, 
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column 3). Participant A2 is a 24 year old female with BMI 23 kg/m3, resting blood pressure 134/81 mmHg, awake ambulatory blood pressure 
122/77 mmHg, recording 20 minutes of vigorous activity and 21 hours of moderate to vigorous activity per week measured on trixial 
accelerometer, non-smoker with alcohol intake less than 2 drinks per week, blood pressure at peak exercise measured 180/90 mmHg, total 
cholesterol 127 mg/dl and fasting blood glucose 84 mg/dl. Participant A2 vessel density measures 12.6 vessels/cm3, she has 8 white matter 
hyperintensity lesions and cerebral blood flow was 83ml/100g/min (brighter intensity on colour scale, column 3). 
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